Prescription drug · ANDA
Glipizide NDC 69584-309
Glipizide 5 mg/1 · Tablet · Oral · Oxford Pharmaceuticals, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 69584-309-09 | 6958403090969584030909 | 90 TABLET in 1 BOTTLE (69584-309-09)Marketed from Sep 18, 2026 | |
| 69584-309-10 | 6958403091069584030910 | 100 TABLET in 1 BOTTLE (69584-309-10)Marketed from May 1, 2025 | |
| 69584-309-18 | 6958403091869584030918 | 180 TABLET in 1 BOTTLE (69584-309-18)Marketed from Sep 18, 2026 | |
| 69584-309-36 | 6958403093669584030936 | 360 TABLET in 1 BOTTLE (69584-309-36)Marketed from Sep 18, 2026 | |
| 69584-309-50 | 6958403095069584030950 | 500 TABLET in 1 BOTTLE (69584-309-50)Marketed from May 1, 2025 | |
| 69584-309-90 | 6958403099069584030990 | 1000 TABLET in 1 BOTTLE (69584-309-90)Marketed from May 1, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Glipizide
- Generic name (nonproprietary)
- glipizide
- Active ingredients
- Glipizide — 5 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Oxford Pharmaceuticals, LLCNDC labeler code 69584
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 074378
- Marketing start
- Listing expires
- Other FDA classes
- Sulfonylurea Compounds (Chemical structure)
- Identifiers
- Product ID 69584-309_02a8d094-c2c7-436e-b77e-9889345be1f2SPL ID 02a8d094-c2c7-436e-b77e-9889345be1f2
- Pharmacologic class
- Sulfonylurea
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N469584030909followed by a unit qualifier and the quantityPackage 69584-0309-09. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 69584-309
- What is NDC 69584-309?
- 69584-309 is the product NDC for Glipizide, Glipizide 5 mg/1 tablet, listed with the FDA by Oxford Pharmaceuticals, LLC. It has 6 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Glipizide.
- What is the active ingredient?
- Glipizide.
- Who is the labeler?
- Oxford Pharmaceuticals, LLC, NDC labeler code 69584. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Glipizide?
- 135 other product NDCs are listed under this name. See all Glipizide NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Glipizide products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Glipizide | Glipizide 5 mg/1 | TabletOral | AiPing Pharmaceutical, Inc. | 11788-117 | 11788-0117-0111788-0117-0511788-0117-10 |
| Glipizide | Glipizide 10 mg/1 | TabletOral | AiPing Pharmaceutical, Inc. | 11788-118 | 11788-0118-00 |
| Glipizide | Glipizide 2.5 mg/1 | TabletOral | AiPing Pharmaceutical, Inc. | 11788-120 | 11788-0120-0111788-0120-0511788-0120-10 |
| Glipizide | Glipizide 5 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | 72789-579 | 72789-0579-3072789-0579-6072789-0579-86+3 more |
| Glipizide | Glipizide 10 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | 72789-580 | 72789-0580-3072789-0580-6072789-0580-86+3 more |
| Glipizide | Glipizide 5 mg/1 | TabletOral | Preferred Pharmaceuticals Inc. | 68788-4178 | 68788-4178-0168788-4178-0368788-4178-06+2 more |
| Glipizide | Glipizide 10 mg/1 | TabletOral | Coupler LLC | 67046-0367 | 67046-0367-03 |
| Glipizide | Glipizide 5 mg/1 | TabletOral | Coupler LLC | 67046-0236 | 67046-0236-03 |
| Glipizide | Glipizide 10 mg/1 | TabletOral | Preferred Pharmaceuticals Inc. | 68788-4061 | 68788-4061-0168788-4061-0368788-4061-06+2 more |
| Glipizide | Glipizide 10 mg/1 | TabletOral | Preferred Pharmaceuticals Inc. | 68788-4017 | 68788-4017-0168788-4017-0368788-4017-06+2 more |
Other NDCs under ANDA 074378
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Glipizide | Glipizide 5 mg/1 | TabletOral | Preferred Pharmaceuticals Inc. | 68788-4178 |
| Glipizide | Glipizide 5 mg/1 | TabletOral | Proficient Rx LP | 82804-959 |
| Glipizide | Glipizide 10 mg/1 | TabletOral | Proficient Rx LP | 82804-960 |
| Glipizide | Glipizide 5 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-3133 |
| Glipizide | Glipizide 10 mg/1 | TabletOral | A-S Medication Solutions | 50090-8098 |
| Glipizide | Glipizide 10 mg/1 | TabletOral | Preferred Pharmaceuticals Inc. | 68788-4061 |
| Glipizide | Glipizide 10 mg/1 | TabletOral | Oxford Pharmaceuticals, LLC | 69584-310 |
| Glipizide | Glipizide 10 mg/1 | TabletOral | NuCare Pharmaceuticals, Inc. | 68071-5326 |
| Glipizide | Glipizide 5 mg/1 | TabletOral | A-S Medication Solutions | 50090-8178 |